pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Immunology Society Split Over California’s $8.4 B Proposition 38 Funding Measure

Oct 19, 2026·read at STAT ↗Neutral

Internal emails obtained by STAT reveal a sharp split within the American Association of Immunologists over California’s Proposition 38, a ballot measure that would direct $8.4 billion of taxpayer money to immunology research.

The association’s policy and advocacy committee, after learning that a large portion of the funds could flow to a research center co‑founded by billionaire philanthropist Gary Michelson, recommended that the society withdraw its endorsement of the measure.

Despite that recommendation, the governing council voted in August to maintain the endorsement after meeting with Michelson. According to an email from the director of government affairs, five council members voted to keep the endorsement, one opposed, and two abstained.

The division highlights concerns among members about the potential influence of private donors on the allocation of public research dollars, even as the measure promises a substantial boost to the field.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Top immunology association divided over $8.4-billion California ballot measure to fund the field, emails show”

read at STAT ↗
514 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2
drugs
Immunology3
topics
Immunology3Oncology

related stories

  • 3d agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Oct 9Pfizer pens $500M Enodia pact to join Lilly in emerging protein degrader fieldFierce Biotech
  • Oct 9Opinion: 50 years ago, my colleagues and I pursued basic research science that became revolutionarySTAT
  • Sep 29Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand HengruiFierce Biotech
  • Sep 28Opinion: AI is eroding the barriers that kept biological weapons rareSTAT